| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4871300
Max Phase: Preclinical
Molecular Formula: C17H35NO
Molecular Weight: 269.47
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CCCCCCCCCCCC/C=C/[C@H](O)[C@@H](C)N
Standard InChI: InChI=1S/C17H35NO/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-17(19)16(2)18/h14-17,19H,3-13,18H2,1-2H3/b15-14+/t16-,17+/m1/s1
Standard InChI Key: BJVFMEDGLZWWDO-LTWOGSJMSA-N
Associated Targets(Human)
Acid ceramidase 411 Activities
Associated Targets(non-human)
Alkaline ceramidase 3 54 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 269.47 | Molecular Weight (Monoisotopic): 269.2719 | AlogP: 4.56 | #Rotatable Bonds: 13 |
| Polar Surface Area: 46.25 | Molecular Species: BASE | HBA: 2 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 9.78 | CX LogP: 5.17 | CX LogD: 2.87 |
| Aromatic Rings: 0 | Heavy Atoms: 19 | QED Weighted: 0.38 | Np Likeness Score: 1.24 |
References
| 1. Bielsa N, Casasampere M, Aseeri M, Casas J, Delgado A, Abad JL, Fabriàs G.. (2021) Discovery of deoxyceramide analogs as highly selective ACER3 inhibitors in live cells., 216 [PMID:33677352] [10.1016/j.ejmech.2021.113296] |
Source
Source(1):